Advertisement

Topics

Boehringer Ingelheim And Vanderbilt Univ. To Develop Novel Cancer Treatment

09:18 EDT 14 Mar 2018 | Pharmaceutical Processing

Boehringer Ingelheim and Vanderbilt University will extend their existing collaboration to develop novel anti-cancer compounds, focusing on new chemical therapeutics.
Contributed Author: 
Boehringer Ingelheim Pharmaceuticals
Topics: 

Original Article: Boehringer Ingelheim And Vanderbilt Univ. To Develop Novel Cancer Treatment

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim And Vanderbilt Univ. To Develop Novel Cancer Treatment"

Advertisement
Quick Search
Advertisement
Advertisement